✦ LIBER ✦

Association of aneuploidy in index adenomas with metachronous colorectal adenoma development and a comparison

✍ Scribed by Gerrit Griffioen; Cees J. Cornelisse; Hein W. Verspaget; Cees F. M. Sier; Frits Eulderink; Fred T. Bosman; Cornelis B. H. W. Lamers

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 769 KB
Volume: 70
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19921015)70:8<2035::aid-cncr2820700804>3.0.co;2-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicting the risk of metachronous colo

Predicting the risk of metachronous colorectal cancer in patients with rectosigmoid adenomas using quantitative pathological features. A case-control study

✍ Meijer, Gerrit A.; Baak, Jan P. A.; Talbot, Ian C.; Atkin, Wendy S.; Meuwissen, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

The prognostic value of quantitative pathological features in rectosigmoid adenomas was investigated, in search of more precise identifiers of adenoma-bearing patients at high risk of metachronous colorectal cancer. In a 'nested case-control study' design, 21 cases with metachronous colon cancer dur

Rectal epithelial proliferation in perso

Rectal epithelial proliferation in persons with or without a history of adenoma and its association with diet and lifestyle habits

✍ Paul Rozen; Flora Lubin; Naomi Papo; Gershom Zajicek 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## BACKGROUND. Rectal epithelial proliferation (REP) measurements are used as a biomarker of risk for colorectal neoplasia and response to chemoprevention. The authors evaluated REP in screenees with and without a history of adenoma and its association with demographic and adenoma characteristics,

Prognostic index for the development of

Prognostic index for the development of liver metastases in patients with colorectal cancer

✍ Professor I. Taylor; M. A. Mullee; M. J. Campbell 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB 👁 2 views

## Abstract The incidence of synchronous and metachronous liver metastases in patients with colorectal cancer is extremely high. Approximately 25 per cent of patients will have overt liver metastases at the time of presentation, and in the remainder up to 40 per cent will eventually develop liver m